These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

250 related articles for article (PubMed ID: 23477159)

  • 41. ["Re-evaluation upon suspected event" is an approach for post-marketing clinical study: lessons from adverse drug events related to Bupleuri Radix preparations].
    Wu SX; Sun HF; Yang XH; Long HZ; Ye ZG; Ji SL; Zhang L
    Zhongguo Zhong Yao Za Zhi; 2014 Aug; 39(15):2983-8. PubMed ID: 25423845
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Adverse events to Houttuynia injection: A systematic review.
    Wang L; Cui X; Cheng L; Yuan Q; Li T; Li Y; Deng S; Shang H; Bian Z
    J Evid Based Med; 2010 Aug; 3(3):168-76. PubMed ID: 21349062
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Retrospective study of adverse events of Polygonum multiflorum and risk control].
    Zhang L; Yang X; Sun Z; Qu Y
    Zhongguo Zhong Yao Za Zhi; 2009 Jul; 34(13):1724-9. PubMed ID: 19873791
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Characteristics associated with ability to prevent adverse drug reactions in hospitalized patients.
    Seeger JD; Kong SX; Schumock GT
    Pharmacotherapy; 1998; 18(6):1284-9. PubMed ID: 9855328
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Adulteration of proprietary Chinese medicines and health products with undeclared drugs: experience of a tertiary toxicology laboratory in Hong Kong.
    Ching CK; Chen SPL; Lee HHC; Lam YH; Ng SW; Chen ML; Tang MHY; Chan SSS; Ng CWY; Cheung JWL; Chan TYC; Lau NKC; Chong YK; Mak TWL
    Br J Clin Pharmacol; 2018 Jan; 84(1):172-178. PubMed ID: 28965348
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Paediatric adverse drug reactions reported in Sweden from 1987 to 2001.
    Kimland E; Rane A; Ufer M; Panagiotidis G
    Pharmacoepidemiol Drug Saf; 2005 Jul; 14(7):493-9. PubMed ID: 15918163
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Thinking about evaluation of proprietary Chinese medicines containing toxic herbs during switch process of non-prescription drugs].
    Xia D; Cheng G; Li X; Zhou J; Xiao A; Zhang C; Du X
    Zhongguo Zhong Yao Za Zhi; 2010 Dec; 35(24):3389-92. PubMed ID: 21438414
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Research on establishment of clinical safety intensive hospital monitoring net of traditional Chinese medicine injection].
    Wang LX; Xie YM; Wang ZF
    Zhongguo Zhong Yao Za Zhi; 2012 Sep; 37(18):2692-4. PubMed ID: 23285910
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Simultaneous vaccination of Chinese applicants for a United States immigrant visa.
    Hua L; Hongtao H; Shunqin W; Jinping G; Jiandong C; Zhaoliang L; Xinwen F
    Travel Med Infect Dis; 2008 May; 6(3):130-6. PubMed ID: 18486068
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Explore pros and cons of proproetary Chinese medicines and Western medicines].
    Jin YQ; Jiang ZY
    Zhongguo Zhong Yao Za Zhi; 2008 Oct; 33(20):2407-9. PubMed ID: 19157140
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Efficacy of a Chinese herbal proprietary medicine (Hemp Seed Pill) for functional constipation.
    Cheng CW; Bian ZX; Zhu LX; Wu JC; Sung JJ
    Am J Gastroenterol; 2011 Jan; 106(1):120-9. PubMed ID: 21045817
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Adverse drug reactions induced by Mailuoning injection: literature review on 162 cases].
    Xing GY; Li CY; Yang YX
    Zhongguo Zhong Yao Za Zhi; 2008 Jun; 33(11):1322-6. PubMed ID: 18831218
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Drug use and adverse event monitoring in German children.
    Lewis MA; Kühl-Habich D; von Rosen J
    Int J Clin Pharmacol Ther; 2001 Nov; 39(11):507-12. PubMed ID: 11727973
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Safety research in Chinese medicines based on application of data mining].
    Tong Y; Yang J; Li C; He W
    Zhongguo Zhong Yao Za Zhi; 2011 Nov; 36(21):3047-50. PubMed ID: 22308699
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Chinese patent medicine as a potential source of mercury poisoning.
    Kang-Yum E; Oransky SH
    Vet Hum Toxicol; 1992 Jun; 34(3):235-8. PubMed ID: 1609495
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Meta-analysis on efficacy and safety of external use of tradition Chinese medicines and western medicines in treating knee osteoarthritis].
    Xu YP; Xie LM; Wang WY
    Zhongguo Zhong Yao Za Zhi; 2012 Oct; 37(19):2977-84. PubMed ID: 23270246
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [Meta-analysis of Shenmai injection treatment for acute myocardial infarction].
    Hu J; Zhang W; Xie YM; Wang LX; Nie XL; Zhang YL
    Zhongguo Zhong Yao Za Zhi; 2012 Sep; 37(18):2760-7. PubMed ID: 23285929
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Adverse drug reactions in childhood: a review of prospective studies and safety alerts.
    Clavenna A; Bonati M
    Arch Dis Child; 2009 Sep; 94(9):724-8. PubMed ID: 19531524
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Surveillance for safety after immunization: Vaccine Adverse Event Reporting System (VAERS)--United States, 1991-2001.
    Zhou W; Pool V; Iskander JK; English-Bullard R; Ball R; Wise RP; Haber P; Pless RP; Mootrey G; Ellenberg SS; Braun MM; Chen RT
    MMWR Surveill Summ; 2003 Jan; 52(1):1-24. PubMed ID: 12825543
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [Core elements of safety monitoring report of medicines(Chinese patent medicines)].
    Wang GQ; Liao X; Xie YM
    Zhongguo Zhong Yao Za Zhi; 2016 Dec; 41(24):4483-4487. PubMed ID: 28936827
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.